Search

Your search keyword '"Hilsenbeck, Susan G."' showing total 1,212 results
Start Over Author "Hilsenbeck, Susan G."
1,212 results on '"Hilsenbeck, Susan G."'

53. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer

Author

Nair, Amritha, Chung, Hsiang-Ching, Sun, Tingting, Tyagi, Siddhartha, Dobrolecki, Lacey E, Dominguez-Vidana, Rocio, Kurley, Sarah J, Orellana, Mayra, Renwick, Alexander, Henke, David M, Katsonis, Panagiotis, Schmitt, Earlene, Chan, Doug W, Li, Hui, Mao, Sufeng, Petrovic, Ivana, Creighton, Chad J, Gutierrez, Carolina, Dubrulle, Julien, Stossi, Fabio, Tyner, Jeffrey W, Lichtarge, Olivier, Lin, Charles Y, Zhang, Bing, Scott, Kenneth L, Hilsenbeck, Susan G, Sun, Jinpeng, Yu, Xiao, Osborne, C Kent, Schiff, Rachel, Christensen, James G, Shields, David J, Rimawi, Mothaffar F, Ellis, Matthew J, Shaw, Chad A, Lewis, Michael T, and Westbrook, Thomas F

Subjects
Cell receptors -- Health aspects, Esterases -- Health aspects, Gene mutation -- Health aspects, Breast cancer -- Genetic aspects -- Development and progression -- Care and treatment, Gene expression -- Health aspects, Biological sciences, Health
Abstract

Author(s): Amritha Nair [1, 2]; Hsiang-Ching Chung [1, 2, 3]; Tingting Sun [1, 2]; Siddhartha Tyagi [1, 2]; Lacey E Dobrolecki [4]; Rocio Dominguez-Vidana [1, 2, 3]; Sarah J Kurley [...]

Published
2018
Full Text
View/download PDF

55. A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer

Author

Veeraraghavan, Jamunarani, primary, Gutierrez, Carolina, additional, De Angelis, Carmine, additional, Davis, Robert, additional, Wang, Tao, additional, Pascual, Tomas, additional, Selenica, Pier, additional, Sanchez, Katherine, additional, Nitta, Hiroaki, additional, Kapadia, Monesh, additional, Pavlick, Anne C., additional, Galvan, Patricia, additional, Rexer, Brent, additional, Forero-Torres, Andres, additional, Nanda, Rita, additional, Storniolo, Anna M., additional, Krop, Ian E., additional, Goetz, Matthew P., additional, Nangia, Julie R., additional, Wolff, Antonio C., additional, Weigelt, Britta, additional, Reis-Filho, Jorge S., additional, Hilsenbeck, Susan G., additional, Prat, Aleix, additional, Osborne, C. Kent, additional, Schiff, Rachel, additional, and Rimawi, Mothaffar F., additional

Published
2023
Full Text
View/download PDF

59. Supplementary table 3 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

60. Data from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

63. Supplementary Figure 1 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

64. Supplementary Figure 2 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

65. Supplementary table 4 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

66. Supplementary table 2 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

67. Supplementary table 1 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

70. Legend for supplementay figures from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Author

Malorni, Luca, primary, Giuliano, Mario, primary, Migliaccio, Ilenia, primary, Wang, Tao, primary, Creighton, Chad J., primary, Lupien, Mathieu, primary, Fu, Xiaoyong, primary, Hilsenbeck, Susan G., primary, Healy, Nuala, primary, De Angelis, Carmine, primary, Mazumdar, Abhijit, primary, Trivedi, Meghana V., primary, Massarweh, Suleiman, primary, Gutierrez, Carolina, primary, De Placido, Sabino, primary, Jeselsohn, Rinath, primary, Brown, Myles, primary, Brown, Powel H., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

72. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Author

Fu, Xiaoyong, Jeselsohn, Rinath, Pereira, Resel, Hollingsworth, Emporia F., Creighton, Chad J., Li, Fugen, Shea, Martin, Nardone, Agostina, De Angelis, Carmine, Heiser, Laura M., Anur, Pavana, Wang, Nicholas, Grasso, Catherine S., Spellman, Paul T., Griffith, Obi L., Tsimelzon, Anna, Gutierrez, Carolina, Huang, Shixia, Edwards, Dean P., Trivedi, Meghana V., Rimawi, Mothaffar F., Lopez-Terrada, Dolores, Hilsenbeck, Susan G., Gray, Joe W., Brown, Myles, Osborne, C. Kent, and Schiff, Rachel

Published
2016

73. The Signaling Pathways Project, an integrated ‘omics knowledgebase for mammalian cellular signaling pathways

Author

Ochsner, Scott A., Abraham, David, Martin, Kirt, Ding, Wei, McOwiti, Apollo, Kankanamge, Wasula, Wang, Zichen, Andreano, Kaitlyn, Hamilton, Ross A., Chen, Yue, Hamilton, Angelica, Gantner, Marin L., Dehart, Michael, Qu, Shijing, Hilsenbeck, Susan G., Becnel, Lauren B., Bridges, Dave, Ma’ayan, Avi, Huss, Janice M., Stossi, Fabio, Foulds, Charles E., Kralli, Anastasia, McDonnell, Donald P., and McKenna, Neil J.

Published
2019
Full Text
View/download PDF

74. Supplementary Table 1 from TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer

Author

Rimawi, Mothaffar F., primary, Niravath, Polly, primary, Wang, Tao, primary, Rexer, Brent N., primary, Forero, Andres, primary, Wolff, Antonio C., primary, Nanda, Rita, primary, Storniolo, Anna M., primary, Krop, Ian, primary, Goetz, Matthew P., primary, Nangia, Julie R., primary, Jiralerspong, Sao, primary, Pavlick, Anne, primary, Veeraraghavan, Jamunarani, primary, De Angelis, Carmine, primary, Gutierrez, Carolina, primary, Schiff, Rachel, primary, Hilsenbeck, Susan G., primary, and Osborne, C. Kent, primary

Published
2023
Full Text
View/download PDF

75. Data from Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes

Author

Bu, Wen, primary, Liu, Zhenyu, primary, Jiang, Weiyu, primary, Nagi, Chandandeep, primary, Huang, Shixia, primary, Edwards, Dean P., primary, Jo, Eunji, primary, Mo, Qianxing, primary, Creighton, Chad J., primary, Hilsenbeck, Susan G., primary, Leavitt, Andrew D., primary, Lewis, Michael T., primary, Wong, Stephen T. C., primary, and Li, Yi, primary

Published
2023
Full Text
View/download PDF

76. Supplementary Tables from HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

Author

Xu, Xiaowei, primary, De Angelis, Carmine, primary, Burke, Kathleen A., primary, Nardone, Agostina, primary, Hu, Huizhong, primary, Qin, Lanfang, primary, Veeraraghavan, Jamunarani, primary, Sethunath, Vidyalakshmi, primary, Heiser, Laura M., primary, Wang, Nicholas, primary, Ng, Charlotte K.Y., primary, Chen, Edward S., primary, Renwick, Alexander, primary, Wang, Tao, primary, Nanda, Sarmistha, primary, Shea, Martin, primary, Mitchell, Tamika, primary, Rajendran, Mahitha, primary, Waters, Ian, primary, Zabransky, Daniel J., primary, Scott, Kenneth L., primary, Gutierrez, Carolina, primary, Nagi, Chandandeep, primary, Geyer, Felipe C., primary, Chamness, Gary C., primary, Park, Ben H., primary, Shaw, Chad A., primary, Hilsenbeck, Susan G., primary, Rimawi, Mothaffar F., primary, Gray, Joe W., primary, Weigelt, Britta, primary, Reis-Filho, Jorge S., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

77. Supplementary information from HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

Author

Xu, Xiaowei, primary, De Angelis, Carmine, primary, Burke, Kathleen A., primary, Nardone, Agostina, primary, Hu, Huizhong, primary, Qin, Lanfang, primary, Veeraraghavan, Jamunarani, primary, Sethunath, Vidyalakshmi, primary, Heiser, Laura M., primary, Wang, Nicholas, primary, Ng, Charlotte K.Y., primary, Chen, Edward S., primary, Renwick, Alexander, primary, Wang, Tao, primary, Nanda, Sarmistha, primary, Shea, Martin, primary, Mitchell, Tamika, primary, Rajendran, Mahitha, primary, Waters, Ian, primary, Zabransky, Daniel J., primary, Scott, Kenneth L., primary, Gutierrez, Carolina, primary, Nagi, Chandandeep, primary, Geyer, Felipe C., primary, Chamness, Gary C., primary, Park, Ben H., primary, Shaw, Chad A., primary, Hilsenbeck, Susan G., primary, Rimawi, Mothaffar F., primary, Gray, Joe W., primary, Weigelt, Britta, primary, Reis-Filho, Jorge S., primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

78. Data from TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer

Author

Rimawi, Mothaffar F., primary, Niravath, Polly, primary, Wang, Tao, primary, Rexer, Brent N., primary, Forero, Andres, primary, Wolff, Antonio C., primary, Nanda, Rita, primary, Storniolo, Anna M., primary, Krop, Ian, primary, Goetz, Matthew P., primary, Nangia, Julie R., primary, Jiralerspong, Sao, primary, Pavlick, Anne, primary, Veeraraghavan, Jamunarani, primary, De Angelis, Carmine, primary, Gutierrez, Carolina, primary, Schiff, Rachel, primary, Hilsenbeck, Susan G., primary, and Osborne, C. Kent, primary

Published
2023
Full Text
View/download PDF

79. Supplementary Figure 2 from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

Author

Giuliano, Mario, primary, Hu, Huizhong, primary, Wang, Yen-Chao, primary, Fu, Xiaoyong, primary, Nardone, Agostina, primary, Herrera, Sabrina, primary, Mao, Sufeng, primary, Contreras, Alejandro, primary, Gutierrez, Carolina, primary, Wang, Tao, primary, Hilsenbeck, Susan G., primary, De Angelis, Carmine, primary, Wang, Nicholas J., primary, Heiser, Laura M., primary, Gray, Joe W., primary, Lopez-Tarruella, Sara, primary, Pavlick, Anne C., primary, Trivedi, Meghana V., primary, Chamness, Gary C., primary, Chang, Jenny C., primary, Osborne, C. Kent, primary, Rimawi, Mothaffar F., primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

80. Supplementary Data from Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

Author

De Angelis, Carmine, primary, Nagi, Chandandeep, primary, Hoyt, Cliff C., primary, Liu, Linying, primary, Roman, Kristin, primary, Wang, Chichung, primary, Zheng, Yi, primary, Veeraraghavan, Jamunarani, primary, Sethunath, Vidyalakshmi, primary, Nuciforo, Paolo, primary, Wang, Tao, primary, Tsimelzon, Anna, primary, Mao, Sufeng, primary, Hilsenbeck, Susan G., primary, Trivedi, Meghana V., primary, Cataldo, Maria Letizia, primary, Pavlick, Anne, primary, Wolff, Antonio C., primary, Weigelt, Britta, primary, Reis-Filho, Jorge S., primary, Prat, Aleix, primary, Gutierrez, Carolina, primary, Osborne, Charles Kent, primary, Rimawi, Mothaffar F., primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

83. Supplementary Figures from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Author

De Angelis, Carmine, primary, Fu, Xiaoyong, primary, Cataldo, Maria Letizia, primary, Nardone, Agostina, primary, Pereira, Resel, primary, Veeraraghavan, Jamunarani, primary, Nanda, Sarmistha, primary, Qin, Lanfang, primary, Sethunath, Vidyalakshmi, primary, Wang, Tao, primary, Hilsenbeck, Susan G., primary, Benelli, Matteo, primary, Migliaccio, Ilenia, primary, Guarducci, Cristina, primary, Malorni, Luca, primary, Litchfield, Lacey M., primary, Liu, Jiangang, primary, Donaldson, Joshua, primary, Selenica, Pier, primary, Brown, David N., primary, Weigelt, Britta, primary, Reis-Filho, Jorge S., primary, Park, Ben H., primary, Hurvitz, Sara A., primary, Slamon, Dennis J., primary, Rimawi, Mothaffar F., primary, Jansen, Valerie M., primary, Jeselsohn, Rinath, primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

84. Supplementary Figure 1 from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

Author

Giuliano, Mario, primary, Hu, Huizhong, primary, Wang, Yen-Chao, primary, Fu, Xiaoyong, primary, Nardone, Agostina, primary, Herrera, Sabrina, primary, Mao, Sufeng, primary, Contreras, Alejandro, primary, Gutierrez, Carolina, primary, Wang, Tao, primary, Hilsenbeck, Susan G., primary, De Angelis, Carmine, primary, Wang, Nicholas J., primary, Heiser, Laura M., primary, Gray, Joe W., primary, Lopez-Tarruella, Sara, primary, Pavlick, Anne C., primary, Trivedi, Meghana V., primary, Chamness, Gary C., primary, Chang, Jenny C., primary, Osborne, C. Kent, primary, Rimawi, Mothaffar F., primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

87. Supplementary Table 2 from TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer

Author

Rimawi, Mothaffar F., primary, Niravath, Polly, primary, Wang, Tao, primary, Rexer, Brent N., primary, Forero, Andres, primary, Wolff, Antonio C., primary, Nanda, Rita, primary, Storniolo, Anna M., primary, Krop, Ian, primary, Goetz, Matthew P., primary, Nangia, Julie R., primary, Jiralerspong, Sao, primary, Pavlick, Anne, primary, Veeraraghavan, Jamunarani, primary, De Angelis, Carmine, primary, Gutierrez, Carolina, primary, Schiff, Rachel, primary, Hilsenbeck, Susan G., primary, and Osborne, C. Kent, primary

Published
2023
Full Text
View/download PDF

89. Figure S8 from Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes

Author

Bu, Wen, primary, Liu, Zhenyu, primary, Jiang, Weiyu, primary, Nagi, Chandandeep, primary, Huang, Shixia, primary, Edwards, Dean P., primary, Jo, Eunji, primary, Mo, Qianxing, primary, Creighton, Chad J., primary, Hilsenbeck, Susan G., primary, Leavitt, Andrew D., primary, Lewis, Michael T., primary, Wong, Stephen T. C., primary, and Li, Yi, primary

Published
2023
Full Text
View/download PDF

90. Data from Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

Author

Burstein, Matthew D., primary, Tsimelzon, Anna, primary, Poage, Graham M., primary, Covington, Kyle R., primary, Contreras, Alejandro, primary, Fuqua, Suzanne A.W., primary, Savage, Michelle I, primary, Osborne, C. Kent, primary, Hilsenbeck, Susan G., primary, Chang, Jenny C., primary, Mills, Gordon B., primary, Lau, Ching C., primary, and Brown, Powel H., primary

Published
2023
Full Text
View/download PDF

91. Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Author

De Angelis, Carmine, primary, Fu, Xiaoyong, primary, Cataldo, Maria Letizia, primary, Nardone, Agostina, primary, Pereira, Resel, primary, Veeraraghavan, Jamunarani, primary, Nanda, Sarmistha, primary, Qin, Lanfang, primary, Sethunath, Vidyalakshmi, primary, Wang, Tao, primary, Hilsenbeck, Susan G., primary, Benelli, Matteo, primary, Migliaccio, Ilenia, primary, Guarducci, Cristina, primary, Malorni, Luca, primary, Litchfield, Lacey M., primary, Liu, Jiangang, primary, Donaldson, Joshua, primary, Selenica, Pier, primary, Brown, David N., primary, Weigelt, Britta, primary, Reis-Filho, Jorge S., primary, Park, Ben H., primary, Hurvitz, Sara A., primary, Slamon, Dennis J., primary, Rimawi, Mothaffar F., primary, Jansen, Valerie M., primary, Jeselsohn, Rinath, primary, Osborne, C. Kent, primary, and Schiff, Rachel, primary

Published
2023
Full Text
View/download PDF

94. Supplementary Table Set S11-S18 from Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

Author

Burstein, Matthew D., primary, Tsimelzon, Anna, primary, Poage, Graham M., primary, Covington, Kyle R., primary, Contreras, Alejandro, primary, Fuqua, Suzanne A.W., primary, Savage, Michelle I, primary, Osborne, C. Kent, primary, Hilsenbeck, Susan G., primary, Chang, Jenny C., primary, Mills, Gordon B., primary, Lau, Ching C., primary, and Brown, Powel H., primary

Published
2023
Full Text
View/download PDF

97. Supplementary Figures S1-S4 from High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy

Author

Litzenburger, Beate C., primary, Creighton, Chad J., primary, Tsimelzon, Anna, primary, Chan, Bonita T., primary, Hilsenbeck, Susan G., primary, Wang, Tao, primary, Carboni, Joan M., primary, Gottardis, Marco M., primary, Huang, Fei, primary, Chang, Jenny C., primary, Lewis, Michael T., primary, Rimawi, Mothaffar F., primary, and Lee, Adrian V., primary

Published
2023
Full Text
View/download PDF

98. Auxiliary Supplementary File from Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Author

Wang, Xian, primary, Veeraraghavan, Jamunarani, primary, Liu, Chia-Chia, primary, Cao, Xixi, primary, Qin, Lanfang, primary, Kim, Jin-Ah, primary, Tan, Ying, primary, Loo, Suet Kee, primary, Hu, Yiheng, primary, Lin, Ling, primary, Lee, Sanghoon, primary, Shea, Martin J., primary, Mitchell, Tamika, primary, Li, Shunqiang, primary, Ellis, Matthew J., primary, Hilsenbeck, Susan G., primary, Schiff, Rachel, primary, and Wang, Xiao-Song, primary

Published
2023
Full Text
View/download PDF

99. Data from A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis

Author

Yue, Fei, primary, Jiang, Weiyu, primary, Ku, Amy T., primary, Young, Adelaide I.J., primary, Zhang, Weijie, primary, Souto, Eric P., primary, Gao, Yankun, primary, Yu, Zihan, primary, Wang, Yi, primary, Creighton, Chad J., primary, Nagi, Chandandeep, primary, Wang, Tao, primary, Hilsenbeck, Susan G., primary, Feng, Xin-Hua, primary, Huang, Shixia, primary, Coarfa, Cristian, primary, Zhang, Xiang H.-F., primary, Liu, Qingyun, primary, Lin, Xia, primary, and Li, Yi, primary

Published
2023
Full Text
View/download PDF

100. Data from High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy

Author

Litzenburger, Beate C., primary, Creighton, Chad J., primary, Tsimelzon, Anna, primary, Chan, Bonita T., primary, Hilsenbeck, Susan G., primary, Wang, Tao, primary, Carboni, Joan M., primary, Gottardis, Marco M., primary, Huang, Fei, primary, Chang, Jenny C., primary, Lewis, Michael T., primary, Rimawi, Mothaffar F., primary, and Lee, Adrian V., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results